Tech Company Financing Transactions
SentreHEART Funding Round
On 9/29/2016, SentreHEART secured $35 million in Series D financing from Decheng Capital, Deerfield Capital and Prospect Venture Partners.
Transaction Overview
Company Name
Announced On
9/29/2016
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series D
Investors
Proceeds Purpose
The proceeds will be utilized to complete the aMAZE (alternative-MAZE) randomized, pivotal clinical trial evaluating the use of the LARIAT device for closure of the LAA as an adjunctive treatment to ablation in patients with persistent or longstanding persistent atrial fibrillation (AFib).
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
300 Saginaw Dr.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
SentreHEART, Inc. is developing minimally invasive devices to protect and treat disorders of the heart.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Russell Seiber
Chief Financial Officer
Christopher Lowe
VP - Operations
Robert Strasser
VP - R & D
Greg Fung
VP - Regulatory Affairs
Pam Simons
Browse more venture capital transactions:
Prev: 9/29/2016: LoftSmart venture capital transaction
Next: 9/29/2016: OpenSesame venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs